Less than six months after a series A fundraise, AI drug developer Chai Discovery has brewed up a $130 million series B to ...

Explore our campus, meet lecturers and current students, and learn more about what it's like to study at Manchester. The University holds regular open days where you will have the opportunity to tour ...

Article ‘Count’ and ‘Share’ for Research Center for Computer-aided Drug Discovery, SIAT CAS based on listed parameters only. The articles listed below published by authors from Research Center for ...

Computer-aided drug design (CADD) that combines computational chemistry, molecular modeling, and rational drug design with artificial intelligence (AI) and machine learning is rapidly changing the ...

Chai Discovery, an artificial intelligence drug-discovery company backed by Sam Altman’s OpenAI, has secured $130 million ...

Chai Discovery, an artificial intelligence drug-discovery company backed by OpenAI, has raised $130 million to build a ...

Denmark unveiled an Nvidia-powered supercomputer that will be used by researchers from Novo Nordisk A/S and other Danish pharmaceutical companies as they seek novel drugs and smarter trial designs.

How are we improving the way the field of drug discovery creates machine learning algorithms to predict a protein’s interactions with a small molecule? The drug development pipeline is a costly and ...

Chai is building foundation models for drug discovery, specifically to predict interactions between molecules so they could ...

The Series B financing round, co-led by Oak HC/FT and General Catalyst, values the company at $1.3 billion. This funding comes just three months after the startup’s previous round and brings its total ...